Ghent University Academic Bibliography

Journal Article
A1
open access

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry : a multicentric study

Sebastian Böttcher, Robby Engelmann, Georgiana Grigore, Paula Carolina Fernandez, Joana Caetano, Juan Flores-Montero, Vincent H.J. van der Velden, Michaela Novakova, Jan Philippé (UGent) , Matthias Ritgen, et al.

(2022) BLOOD ADVANCES. 6(3). p.976-992

Add to list

Journal Article
A1
open access

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, et al.

(2022) BLOOD ADVANCES. 6(4). p.1115-1125

Add to list

Journal Article
A1
open access

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Tim Pieters (UGent) , André Pedro Pinto De Almeida (UGent) , Sara T'Sas (UGent) , Kelly Lemeire (UGent) , Tino Hochepied (UGent) , Geert Berx (UGent) , Alex Kentsis, Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) BLOOD ADVANCES. 6(10). p.2987-2991

Add to list

Journal Article
open access

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A. Burger, Peter Hillmen, Steve E. Coutre, Claire Dearden, Sebastian Grosicki, et al.

(2022) BLOOD ADVANCES. 6(11). p.3440-3450

Add to list

Journal Article
A1
open access

Hapin1b, a central organizer of the ECM, modulates kit signaling to control developmental hematopoiesis in zebrafish

Christopher B. Mahony, Pietro Cacialli, Corentin Pasche, Rui Monteiro, Savvas Savvides (UGent) and Julien Y. Bertrand

(2021) BLOOD ADVANCES. 5(23). p.4935-4948

Add to list

Journal Article
A1
open access

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Bob Lowenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, et al.

(2021) BLOOD ADVANCES. 5(4). p.1110-1121

Add to list

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Alessandra Di Grande, Sofie Peirs (UGent) , Paul D. Donovan, Maaike Van Trimpont (UGent) , Julie Morscio (UGent) , Béatrice Lintermans (UGent) , Lindy Reunes (UGent) , Niels Vandamme (UGent) , Steven Goossens (UGent) , Hien Anh Nguyen, et al.

(2021) BLOOD ADVANCES. 5(7). p.1963-1976

Add to list

Journal Article
A1
open access

Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

Jochen Buechner, Stephan A. Grupp, Hidefumi Hiramatsu, David T. Teachey, Susana Rives, Theodore W. Laetsch, Gregory A. Yanik, Patricia Wood, Rakesh Awasthi, Lan Yi, et al.

(2021) BLOOD ADVANCES. 5(2). p.593-601

Add to list

Journal Article
A1
open access

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens (UGent) , Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, et al.

(2021) BLOOD ADVANCES. 5(9). p.2325-2338

Add to list

Large-scale circular RNA deregulation in T-ALL : unlocking unique ectopic expression of molecular subtypes

Alessia Buratin, Maddalena Paganin, Enrico Gaffo, Anna Dal Molin, Juliette Roels (UGent) , Giuseppe Germano, Maria Teresa Siddi, Valentina Serafin, Matthias De Decker, Stéphanie Gachet, et al.

(2020) BLOOD ADVANCES. 4(23). p.5902-5914

Academic Bibliography

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry : a multicentric study

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Hapin1b, a central organizer of the ECM, modulates kit signaling to control developmental hematopoiesis in zebrafish

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death

Large-scale circular RNA deregulation in T-ALL : unlocking unique ectopic expression of molecular subtypes

Contents

Support

Contact